Loading...

KOBO Kobo Biotech Ltd Business Restructuring Announcement

Kb B

KB

Kobo Biotech Ltd

(KOBO)

2026 Announcement

Resolution plan approval

Regulatory Compliance

Regulatory update

Trading Window Closure

Regulatory compliance

Regulatory Compliance

Regulatory compliance

Regulatory Compliance

Regulatory Compliance

Regulatory Compliance

Regulatory Compliance

CIRP Meeting Update

CIRP Meeting Notice

Creditors Meeting

CIRP Meeting Held

Creditors Meeting Outcome

Creditor Meeting

CIRP Meeting Outcome

Insolvency Meeting

CIRP Meeting Notice

Creditors Meeting Outcome

Creditors Meeting

Creditors Meeting

CIRP Meeting Outcome

Creditors Meeting

CIRP Meeting Outcome

Creditor Meeting

CIRP Invitation

Insolvency Meeting Outcome

Committee Meeting Held

Insolvency Process Initiated

IRP Replacement

Creditors Meeting

Bankruptcy Announcement

Insolvency Announcement

Insolvency Process

Insolvency Process

CIRP Meeting Notice

Insolvency Announcement

Certificate Submission

Resignation Announcement

Compliance Report Submission

Resignation of Director

Insolvency Application Admi...

Compliance Certificate Subm...

Certificate Submission

Certificate Submission

Regulation 74(5) Certificate

Related Party Transactions

Certificate Submission

Financial Statements

Secondary Offerings

Management changes

Related Party Transactions

External Links:

Data:

NCLT approves Kobo Biotech’s CIRP resolution plan, enabling merger with Beaufond Industries and subsequent demerger, with post-CIRP net worth to be determined.

AI Assistant

Kobo Biotech Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.